Stay updated on Talquetamab Dose Escalation in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.

Latest updates to the Talquetamab Dose Escalation in Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRecruitment for the study is no longer open to new participants. The record has been updated to revision v3.6.0, and the previous revision v3.5.5 has been removed.SummaryDifference0.2%

- Check21 days agoChange DetectedThe page's revision label updated from v3.5.4 to v3.5.5, signaling a new build release. This update is a minor internal version change and does not modify study content or user-facing features.SummaryDifference0.0%

- Check42 days agoChange DetectedA new revision entry (v3.5.4) dated 2026-05-08 with an added 'Study Status' section appears in the history, replacing the prior revision entry (v3.5.3) dated 2026-04-13.SummaryDifference0.2%

- Check57 days agoChange DetectedThe study history now shows a new revision tag (v3.5.3), indicating a minor update to the page version of the record.SummaryDifference0.0%

- Check71 days agoChange DetectedA new history entry was added for Study Status with Revision v3.5.2 (dated 2026-04-13), and the prior Revision v3.5.0 was removed (dated 2026-03-12).SummaryDifference0.2%

- Check99 days agoChange DetectedA new version entry dated 2026-03-12 for Study Status (revision v3.5.0) was added to the history, and the prior 2026-02-13 revision (v3.4.3) was removed.SummaryDifference0.2%

Stay in the know with updates to Talquetamab Dose Escalation in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.